Primary sorted CD44+/EPCAM+ cells derived from a 74-year-old male patient, who underwent surgery for stage IIIA NSCLC, were cultured to assess the growth ability of these cells to form tumor spheres in vitro (Figure 4, Panel 1A–1C). Here, CD44 is linked to non-small cell lung carcinoma.